FDA Approves Expanded Indication for Dupixent to Treat Eosinophilic Esophagitis in Pediatric Patients

Posted on by admin
1 min read

The FDA previously approved Dupixent in May 2022 to treat eosinophilic esophagitis in patients aged 12 years and older.

Avatar for admin
admin https://goorre.com

You May Also Like

More From Author

+ There are no comments

Add yours